In this episode of Science Quickly, host Rachel Feltman and science journalist Jane C. Hu trace the surprising journey of psychedelics in the U.S.—from symbolizing the hippie movement of the 1960s to being seen as a panacea for mental illness. But where does science stand on psychedelic therapy? And what does the renewed political push for psychedelics mean for research?

Recommended Reading:

The Microdose, a newsletter supported by the University of California, Berkeley, Center for the Science of Psychedelics

RFK, Jr., says ibogaine holds unprecedented promise for treating depression. Here’s what the science says

RFK, Jr., puts psychedelics on fast track to FDA review and approval

E-mail us at [email protected] if you have any questions, comments or ideas for stories we should cover!

Discover something new everyday: subscribe to Scientific American and sign up for Today in Science, our daily newsletter.

Science Quickly is produced by Rachel Feltman, Fonda Mwangi, Sushmita Pathak and Jeff DelViscio. This episode was edited by Alex Sugiura, with fact-checking by Shayna Posses and Aaron Shattuck. Our theme music was composed by Dominic Smith.

Learn more about your ad choices. Visit megaphone.fm/adchoices